Form 8-K - Current report:
SEC Accession No. 0001104659-19-056511
Filing Date
2019-10-25
Accepted
2019-10-25 16:00:48
Documents
13
Period of Report
2019-10-25
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm1920994d1_8k.htm 8-K 18790
2 EXHIBIT 99.1 tm1920994d1_ex99-1.htm EX-99.1 11532
3 GRAPHIC logo.gif GRAPHIC 3021
4 GRAPHIC slide01.jpg GRAPHIC 99461
5 GRAPHIC slide02.jpg GRAPHIC 86446
6 GRAPHIC slide03.jpg GRAPHIC 66729
7 GRAPHIC slide04.jpg GRAPHIC 90811
8 GRAPHIC slide05.jpg GRAPHIC 79150
9 GRAPHIC slide06.jpg GRAPHIC 85677
10 GRAPHIC slide07.jpg GRAPHIC 71274
11 GRAPHIC slide08.jpg GRAPHIC 71864
12 GRAPHIC slide09.jpg GRAPHIC 61476
13 GRAPHIC slide10.jpg GRAPHIC 81570
  Complete submission text file 0001104659-19-056511.txt   1131268
Mailing Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108
Business Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108 801 994 7383
Lipocine Inc. (Filer) CIK: 0001535955 (see all company filings)

IRS No.: 990370688 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36357 | Film No.: 191169813
SIC: 2834 Pharmaceutical Preparations